 SOUTH PLAINFIELD, N.J., April 7, 2021 PRNewswire -- PTC Therapeutics, Inc. NASDAQ: PTCT will host a webinar in its deep dive series discussing the PTC518 Huntington disease HD program on Thursday, April 15 at 9 a.m. 